W. Kimryn Rathmell was installed as the 17th director of NCI on Dec. 18, 2023.Â
Eric J. Small was elected as president of the American Society of Clinical Oncology beginning in June 2025.Â
Toni K. ChoueiriJhanelle E. GrayClarissa MathiasAbby R. RosenbergToni K. Choueiri, Jhanelle E. Gray, Clarissa Mathias, and Abby R. Rosenberg were elected to the American Society of Clinical Oncology’s board of directors.
David C. Linehan, a surgical oncologist specializing in malignancies of the liver, pancreas, and biliary tract, was named CEO of the University Rochester Medical Center, dean of the School of Medicine and Dentistry, and senior vice president for health sciences.Â
Kristin A. Heath was named executive director of the University of Florida Health Proton Therapy Institute. Kristin A. Heath succeeds Stuart L. Klein, who retired in November 2023 after 18 years.Â
Ramez N. Eskander was named Clinical Trials Office director for oncology at UC San Diego Health and Moores Cancer Center. Eskander succeeds Sandip Patel.
David Swoboda was named clinical director of leukemia at Tampa General Hospital Cancer Institute.
The Convergent Science Cancer Consortium, a consortium using an unconventional approach that emphasizes the integration of diverse scientific disciplines, received a $3.2 million grant from the U.S. Department of Defense.
The University of New Mexico Comprehensive Cancer Center broke ground on a $61M clinic building addition that will enable it to offer treatments unavailable elsewhere in New Mexico.Â
Nationwide Children’s Hospital and The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute opened a $100 million, 55,000 square foot proton therapy center. It is the first treatment facility in central Ohio offering this highly targeted form of radiation therapy for treatment of complex tumors that cannot be removed through surgery.
